Trial Profile
A 12-Week Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Control Study to Evaluate the Antihypertensive Efficacy and Safety of an Exforge (Valsartan/Amlodipine)-Based Regimen Versus a Losartan-Based Regimen in Patients With Stage 2 Systolic Hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2011
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan/hydrochlorothiazide (Primary) ; Amlodipine/valsartan; Losartan; Losartan/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms EXALT
- Sponsors Novartis
- 10 Mar 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 10 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.